Canton Strategic Holdings Stock Price, News & Analysis
Company Description
Canton Strategic Holdings, Inc. (NASDAQ: CNTN) is an operating company focused on Canton Coin, Canton Network infrastructure and clinical-stage biotechnology research and development. The company describes itself as the first publicly traded company to leverage Canton Coin to support the Canton Network's role in digitizing traditional financial markets. Its digital asset strategy centers on Canton Coin acquisition, operation of a Super Validator, participation in network governance and investment in applications that support Canton Network utilization.
The Canton Network is a privacy-enabled blockchain architecture used for institutional financial-market activity. Canton Strategic Holdings participates in that ecosystem through validator operations that support transaction validation and network operations. The company also maintains a Canton-focused digital asset treasury strategy and has arranged regulated custody and operational controls for its digital asset holdings, including cold storage and multi-signature wallet infrastructure.
Digital asset and network activities
The company's Canton Network activities are built around Canton Coin, validator infrastructure and applications intended to expand network use by institutional market participants. Canton Strategic Holdings also participates in Canton Foundation governance. The Canton Foundation is described in company materials as the independent governance body responsible for the operation, standards and validator framework of the Canton Network, including policies related to the Global Synchronizer and broader network operations.
Canton Strategic Holdings established its digital asset strategy through a completed private placement in 2025. Its public disclosures describe this strategy as including Canton Coin acquisition, Super Validator operations, investments in applications that support network utilization and governance participation through the Canton Foundation.
Biotechnology research and development
In addition to its digital asset activities, Canton Strategic Holdings operates a clinical-stage biotechnology research and development arm. The biotech business includes GV104, identified as a flagship clinical asset being developed for respiratory and/or nervous system depression in military personnel and chemical incident responders. The pipeline also includes other potential GV104 indications, GV023 for autoimmune disease approaches and an early-stage multispecific biologic platform.
Canton Strategic Holdings is listed on Nasdaq under the symbol CNTN. Its principal executive offices are in Red Bank, New Jersey.
Stock Performance
Canton Strategic Holdings (CNTN) stock last traded at $2.69, up 13.43% from the previous close. Over the past 12 months, the stock has lost 40.4%. At a market capitalization of $185.0M, CNTN is classified as a micro-cap stock with approximately 69.8M shares outstanding.
CNTN Rankings
Latest News
Canton Strategic Holdings has 5 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings. View all CNTN news →
SEC Filings
Canton Strategic Holdings has filed 5 recent SEC filings, including 1 Form 4, 1 Form 10-Q, 1 Form SCHEDULE 13G/A, 1 Form 10-K. The most recent filing was submitted on May 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CNTN SEC filings →
Insider Radar
Insider selling at Canton Strategic Holdings over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
operating income reached -$20.1M, and net income was -$35.9M. Diluted earnings per share stood at $-1.12. The company generated -$16.1M in operating cash flow. With a current ratio of 5.29, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Canton Strategic Holdings (CNTN) currently stands at 3.3 million shares, down 7.8% from the previous reporting period, representing 6.0% of the float. Over the past 12 months, short interest has increased by 25%. The 6.3 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Canton Strategic Holdings (CNTN) currently stands at 6.3 days, up 22.8% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 24.5% over the past year, indicating either rising short interest or declining trading volume.
CNTN Company Profile & Sector Positioning
Canton Strategic Holdings (CNTN) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ. In monthly performance, the stock ranks #3,076 among all tracked companies.